Amedisys/ US0234361089 /
| 2024-05-22 5:58:10 PM | Chg. -0.08 | Volume | Bid6:03:57 PM | Ask6:03:57 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 96.16USD | -0.08% | 3,061 Turnover: 294,634.60 |
96.01Bid Size: 100 | 96.22Ask Size: 100 | 3.15 bill.USD | - | - |
GlobeNewswire
05-06
The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire
02-22
Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2023
GlobeNewswire
2023-10-25
Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2023
GlobeNewswire
2023-08-31
Amedisys Recognizes Suicide Prevention Awareness Month and Promotes the 988 Suicide & Crisis Lifelin...
GlobeNewswire
2023-08-29
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DBTX, AMED, RETA, SURF
GlobeNewswire
2023-08-29
Moore Kuehn Encourages AMED, DBTX, RETA, and SURF Investors to Contact Law Firm
GlobeNewswire
2022-02-28
Amedisys to Present at the Raymond James & Associates’ 43rd Annual Institutional Investors Conferenc...
GlobeNewswire
2022-02-23
Amedisys Reports Fourth Quarter and Year End 2021 Financial Results; Issues 2022 Guidance
GlobeNewswire
2022-01-31
Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Date
GlobeNewswire
2022-01-10
Amedisys Announces Paul Kusserow’s Retirement as Chief Executive Officer and Appoints Chris Gerard a...
GlobeNewswire
2021-11-30
Amedisys to Present at the Bank of America Securities 2021 Virtual Healthcare Conference
GlobeNewswire
2021-11-02
Amedisys Reports Third Quarter 2021 Financial Results Updates 2021 Guidance
